Citigroup
ZURA icon

Citigroup’s Zura Bio ZURA Stock Holding History

Citigroup’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56K Sell
9,409
-30,350
-76% -$183K ﹤0.01% 4484
2025
Q4 		$208K Buy
39,759
+39,702
+69,653% +$157K ﹤0.01% 3988
2025
Q3 		$247 Sell
57
-9,122
-99% -$16.4K ﹤0.01% 5751
2025
Q2 		$9.64K Sell
9,179
-26,789
-74% -$32K ﹤0.01% 5196
2025
Q1 		$46.4K Sell
35,968
-3,598
-9% -$5.67K ﹤0.01% 4885
2024
Q4 		$98.9K Buy
39,566
+7,468
+23% +$26.6K ﹤0.01% 4846
2024
Q3 		$130K Buy
32,098
+27,741
+637% +$104K ﹤0.01% 4632
2024
Q2 		$15.3K Buy
4,357
+1,162
+36% +$4.74K ﹤0.01% 5063
2024
Q1 		$8.21K Buy
3,195
+683
+27% +$2.42K ﹤0.01% 5244
2023
Q4 		$11.7K Buy
2,512
+2,506
+41,767% +$12.5K ﹤0.01% 5152
2023
Q3 		$39 Sell
6
-2,252
-100% -$15.1K ﹤0.01% 5545
2023
Q2 		$18.5K Buy
+2,258
New +$18.1K ﹤0.01% 4977

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Citigroup's ZURA Position: Q1 2026 in Review

Citigroup reduced its Zura Bio (ZURA) stake by 76% in Q1 2026, selling an estimated $183K and leaving 9,409 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #4484.

Citigroup first reported a position in ZURA in Q2 2023 and has held it in 12 quarters since. The position peaked at $208K in Q4 2025. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Citigroup held 9,409 shares of Zura Bio worth $56K as of Q1 2026.
  • Citigroup sold 30,350 Zura Bio shares in Q1 2026, an estimated $183K.
  • Zura Bio made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4484 holding.
  • Citigroup first reported a position in Zura Bio in Q2 2023 and has held it in 12 quarters since.
  • Citigroup's Zura Bio position peaked at $208K in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.